These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Early childhood BMI trajectories in monogenic obesity due to leptin, leptin receptor, and melanocortin 4 receptor deficiency. Kohlsdorf K; Nunziata A; Funcke JB; Brandt S; von Schnurbein J; Vollbach H; Lennerz B; Fritsch M; Greber-Platzer S; Fröhlich-Reiterer E; Luedeke M; Borck G; Debatin KM; Fischer-Posovszky P; Wabitsch M Int J Obes (Lond); 2018 Sep; 42(9):1602-1609. PubMed ID: 29568105 [TBL] [Abstract][Full Text] [Related]
46. Melanocortin 4 Receptor Gene Sequence Analyses in Diverse Populations. Edwards MA; Tattoli T; Sureja G; Sykes A; Kaniper S; Gerhard GS Genet Test Mol Biomarkers; 2019 Dec; 23(12):877-881. PubMed ID: 31742438 [No Abstract] [Full Text] [Related]
47. The role of polygenic susceptibility to obesity among carriers of pathogenic mutations in MC4R in the UK Biobank population. Chami N; Preuss M; Walker RW; Moscati A; Loos RJF PLoS Med; 2020 Jul; 17(7):e1003196. PubMed ID: 32692746 [TBL] [Abstract][Full Text] [Related]
48. Structural analysis and haplotype diversity in swine LEP and MC4R genes. D'Andrea M; Pilla F; Giuffra E; Waddington D; Archibald AL J Anim Breed Genet; 2008 Apr; 125(2):130-6. PubMed ID: 18363978 [TBL] [Abstract][Full Text] [Related]
49. A Melanocortin-4 Receptor Agonist Induces Skin and Hair Pigmentation in Patients with Monogenic Mutations in the Leptin-Melanocortin Pathway. Kanti V; Puder L; Jahnke I; Krabusch PM; Kottner J; Vogt A; Richter C; Andruck A; Lechner L; Poitou C; Krude H; Gottesdiener K; Clément K; Farooqi IS; Wiegand S; Kühnen P; Blume-Peytavi U Skin Pharmacol Physiol; 2021; 34(6):307-316. PubMed ID: 34058738 [TBL] [Abstract][Full Text] [Related]
50. Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene. Reinehr T; Hebebrand J; Friedel S; Toschke AM; Brumm H; Biebermann H; Hinney A Obesity (Silver Spring); 2009 Feb; 17(2):382-9. PubMed ID: 18997677 [TBL] [Abstract][Full Text] [Related]
51. Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study. Calton MA; Ersoy BA; Zhang S; Kane JP; Malloy MJ; Pullinger CR; Bromberg Y; Pennacchio LA; Dent R; McPherson R; Ahituv N; Vaisse C Hum Mol Genet; 2009 Mar; 18(6):1140-7. PubMed ID: 19091795 [TBL] [Abstract][Full Text] [Related]
52. A Novel Loss of Function Melanocortin-4-Receptor Mutation (MC4R-F313Sfs*29) in Morbid Obesity. Trevellin E; Granzotto M; Host C; Grisan F; De Stefani D; Grinzato A; Lefkimmiatis K; Pagano C; Rizzuto R; Vettor R J Clin Endocrinol Metab; 2021 Mar; 106(3):736-749. PubMed ID: 33247923 [TBL] [Abstract][Full Text] [Related]
53. Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants. Moore BS; Mirshahi UL; Yost EA; Stepanchick AN; Bedrin MD; Styer AM; Jackson KK; Still CD; Breitwieser GE; Gerhard GS; Carey DJ; Mirshahi T PLoS One; 2014; 9(4):e93629. PubMed ID: 24705671 [TBL] [Abstract][Full Text] [Related]
54. Mouse models for V103I and I251L gain of function variants of the human MC4R display decreased adiposity but are not protected against a hypercaloric diet. Rojo D; McCarthy C; Raingo J; Rubinstein M Mol Metab; 2020 Dec; 42():101077. PubMed ID: 32916307 [TBL] [Abstract][Full Text] [Related]
55. Cardiac Phenotype and Tissue Sodium Content in Adolescents With Defects in the Melanocortin System. Puder L; Roth S; Krabusch P; Wiegand S; Opitz R; Bald M; Flück C; Schulz E; Voss E; Markó L; Linz P; Berger F; Müller DN; Kuehne T; Litt MJ; Cone RD; Kühnen P; Kelm M J Clin Endocrinol Metab; 2021 Aug; 106(9):2606-2616. PubMed ID: 34036349 [TBL] [Abstract][Full Text] [Related]
56. Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity. Potoczna N; Branson R; Kral JG; Piec G; Steffen R; Ricklin T; Hoehe MR; Lentes KU; Horber FF J Gastrointest Surg; 2004 Dec; 8(8):971-81; discussion 981-2. PubMed ID: 15585384 [TBL] [Abstract][Full Text] [Related]
57. Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities Study. Hart Sailors ML; Folsom AR; Ballantyne CM; Hoelscher DM; Jackson AS; Linda Kao WH; Pankow JS; Bray MS Diabetes Obes Metab; 2007 Jul; 9(4):548-57. PubMed ID: 17587397 [TBL] [Abstract][Full Text] [Related]
58. Weight and Glycemic Control Outcomes of Bariatric Surgery and Pharmacotherapy in Patients With Melanocortin-4 Receptor Deficiency. Fojas EGF; Radha SK; Ali T; Nadler EP; Lessan N Front Endocrinol (Lausanne); 2021; 12():792354. PubMed ID: 35095762 [TBL] [Abstract][Full Text] [Related]
59. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. Lubrano-Berthelier C; Dubern B; Lacorte JM; Picard F; Shapiro A; Zhang S; Bertrais S; Hercberg S; Basdevant A; Clement K; Vaisse C J Clin Endocrinol Metab; 2006 May; 91(5):1811-8. PubMed ID: 16507637 [TBL] [Abstract][Full Text] [Related]
60. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. Branson R; Potoczna N; Kral JG; Lentes KU; Hoehe MR; Horber FF N Engl J Med; 2003 Mar; 348(12):1096-103. PubMed ID: 12646666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]